Carvedilol less diabetogenic than metoprololBMJ 2007; 335 doi: https://doi.org/10.1136/bmj.39295.705058.DE (Published 16 August 2007) Cite this as: BMJ 2007;335:325
Patients with chronic heart failure are more likely to develop diabetes if treated with metoprolol than carvedilol. A double blind trial (COMET) recruited 3029 patients with heart failure and …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial